Global epidemiology of head and neck cancers: a continuing challenge

B Gupta, NW Johnson, N Kumar - Oncology, 2016 - karger.com
Background: Head and neck cancers (HNCs) continue to remain a significant public health
burden worldwide, causing significant mortality and morbidity despite significant clinical …

Insight on nano drug delivery systems with targeted therapy in treatment of oral cancer

K Vyas, M Rathod, MM Patel - Nanomedicine: Nanotechnology, Biology …, 2023 - Elsevier
Oral cancer is a type of cancer that develops in the mouth and is one of the deadliest
malignancies in the world. Currently surgical, radiation therapy, and chemotherapy are most …

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): a comprehensive analysis by tumour site

P Blanchard, B Baujat, V Holostenco… - Radiotherapy and …, 2011 - Elsevier
INTRODUCTION: The recently updated meta-analysis of chemotherapy in head and neck
cancer (MACH-NC) demonstrated the benefit of the addition of chemotherapy in terms of …

Effect of nutritional interventions on nutritional status, quality of life and mortality in patients with head and neck cancer receiving (chemo) radiotherapy: a systematic …

JAE Langius, MC Zandbergen, SEJ Eerenstein… - Clinical nutrition, 2013 - Elsevier
Background and aims We performed a systematic review to examine the effect of nutritional
interventions on nutritional status, quality of life (QoL) and mortality in patients with head and …

Radiation resistance in head and neck squamous cell carcinoma: dire need for an appropriate sensitizer

MKND Hutchinson, M Mierzwa, NJ D'Silva - Oncogene, 2020 - nature.com
Radiation is a significant treatment for patients with head and neck cancer. Despite
advances to improve treatment, many tumors acquire radiation resistance resulting in poor …

Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions

T Walsh, R Macey, AR Kerr, MW Lingen… - Cochrane Database …, 2021 - cochranelibrary.com
Background Squamous cell carcinoma is the most common form of malignancy of the oral
cavity, and is often proceeded by oral potentially malignant disorders (OPMD). Early …

Controlled drug delivery systems for oral cancer treatment—current status and future perspectives

F Ketabat, M Pundir, F Mohabatpour, L Lobanova… - Pharmaceutics, 2019 - mdpi.com
Oral squamous cell carcinoma (OSCC), which encompasses the oral cavity-derived
malignancies, is a devastating disease causing substantial morbidity and mortality in both …

Targeted Therapy of Oral Squamous Cell Carcinoma with Cancer Cell Membrane Coated Co‐Fc Nanoparticles Via Autophagy Inhibition

J Chen, Z Zhu, Q Pan, Y Bai, M Yu… - Advanced Functional …, 2023 - Wiley Online Library
Systemic chemotherapy for oral squamous cell carcinoma (OSCC) is associated with
multidrug resistance and systemic adverse effects. Cobalt‐ferrocene metal–organic …

Oral cavity and oropharyngeal squamous cell carcinoma in young adults: a review of the literature

E Majchrzak, B Szybiak, A Wegner… - Radiology and …, 2014 - sciendo.com
Background. Head and neck squamous cell carcinoma (HNSCC) is a disease of middle-
aged to elderly adults. However, an increased incidence of HNSCC in young people under …

Cellular and clinical pharmacology of the taxanes docetaxel and paclitaxel–a review

VA de Weger, JH Beijnen, JHM Schellens - Anti-cancer drugs, 2014 - journals.lww.com
Paclitaxel and docetaxel are active against a range of human cancers. Their antitumor
activity is based on stabilization of the microtubule dynamics and thereby disruption of the …